When CSIRO announced it would shed hundreds of research positions, the narrative was predictable: another casualty of budget cuts, another blow to Australian science, another sign that we don’t value research.
But perhaps the question shouldn’t be whether Australia invests enough in research, but whether we’re getting enough return from the research we already fund.
Or have we been optimising for the wrong metric?
The research scoreboard
Australia’s research ecosystem has been playing the wrong game.
We measure success by publications, citations, and grant dollars won. We celebrate researchers who produce the most papers, chase the most funding, start the most projects. What we don’t measure – what we barely even track—is how many discoveries actually make it out of the lab and into the economy and broader society.
The uncomfortable reality is that untold billions of dollars are invested annually in research that never actually translates. Promising discoveries that stall at proof-of-concept and intellectual property and patents that never get commercialised.
What translation-ready actually means
When industry evaluates whether to license university research, they don’t just ask “does the science work?” They ask: Can you reproduce these results? Is your data traceable? Are your methods valid? Can we verify your chain of custody?
They look for systematic evidence of research integrity, not because they doubt the scientists, but because they need assurance the science will scale.
However, much of Australian research still operates as if documentation, process rigor, and data integrity are ‘compliance burden’ rather than commercial prerequisites.
The consequences compound quickly. Projects that can’t demonstrate reproducibility won’t get translated. Research that lacks proper documentation can’t be carried over by the next team. Discoveries that aren’t built on traceable data pipelines can’t survive the scrutiny required for regulatory approval.
We’re not failing to fund enough research. We’re failing to fund research that can actually go somewhere.
The efficiency paradox
Here’s where it gets interesting: improving translation productivity doesn’t require more funding. It requires different infrastructure.
Research with proper quality foundations translates faster, attracts commercial partners earlier, and retains value when custodians of knowledge move on. It’s more efficient, more reproducible, and vastly more efficient.
In other words: better systems create better economics.
The paradox is that quality infrastructure, the documentation practices and process rigor that make research translation-ready, costs relatively little – and isn’t difficult – to implement.
And yet many still think they don’t need it.
The real barrier isn’t budget. It’s culture.
We’ve treated quality systems as ‘regulatory documentation’ for so long that we’ve lost sight of the fact they’re actually the foundations of our productivity infrastructure.
In every other knowledge-intensive industry, systematic quality underpins scale, protects IP, controls risk, and attracts capital. In Australian research, it’s still too often applied late, inconsistently, or not at all.
That gap is no longer sustainable.
An opportunity for improvement
It’s notable that the CSIRO announcement comes amid the Federal Government’s first comprehensive review of Australia’s R&D ecosystem in decades, starting with an examination of how it actually functions.
Rather than surrender to division and derision, the CSIRO’ cuts should compel us all to examine not just how much we fund, but how effectively we translate what we fund.
If the Federal Government’s review focuses purely on funding models and grant structures, we’ll miss the point entirely. We need to look into modernising how research is operationalised—building translation-readiness into the process from day one, not bolting it on at the end.
This is Australia’s chance to leapfrog ahead of other countries who are still wrestling with legacy research cultures, and to nurture a renewed research ecosystem where quality infrastructure is foundational, where translation productivity is measured alongside publication metrics, and where commercial readiness is built into research design rather than retrofitting the year later.
The economic upside is material. Research that translates efficiently requires fewer grants to deliver commercial outcomes.
Projects that are built on quality foundations attract industry partnerships earlier. Discoveries that can survive due diligence can move faster through the valley of death.
Focusing on quality instead of quantity, it is about doing fewer projects that actually complete the journey from discovery to impact.
What “less but better” can look like
The instinct when budgets tighten is to protect the number of projects, even if it means spreading resources thinner.
But that’s precisely backwards.
What if instead of funding 100 projects to publication, we funded 20 projects to translation? What if we measured success not by papers produced, but by discoveries that reached the market?
What if we built quality infrastructure into research grants, ensuring translation-readiness from day one?
The choice ahead
Australia can interpret CSIRO’s cuts as evidence that we need to defend the status quo with more funding.
Or we can read them as evidence that the status quo needs modernising.
One path leads to more of the same: research that struggles to translate, institutions under pressure, workforce instability masked temporarily by funding injections.
The other path leads to a research system built for the economy we actually have – one where translation productivity matters as much as scientific discovery, where quality infrastructure is foundational rather than optional, where fewer projects reach further.
What we do will determine whether Australian research becomes more resilient or more fragile over the next decade.
The timer’s already started.
- Keren Natalia is founder & principal consultant at SmartQMS & Zero to Quality
